- Home
- Equipment
- usa massachusetts
- blood lead
Show results for
Refine by
Blood Lead Equipment Supplied In Usa Massachusetts
5 equipment items found
Manufactured by:NP Medical Inc. based inClinton, MASSACHUSETTS (USA)
Multiple Configurations for Clinical Use. Manufactured with the highest quality, nPulse Extension Sets with neutral needle-free connectors are available in several configurations. We offer various lengths and tubing diameters (microbore and macrobore) to meet diverse applications in a range of clinical settings. The nPulse Needle-Free Connector features neutral fluid displacement at both luer ...
Manufactured by:NP Medical Inc. based inClinton, MASSACHUSETTS (USA)
The nPulse Valve Platform is designed to complement best clinical practices to reduce the risk of catheter-related bloodstream infections (CRBSI), and reflux-induced catheter occlusions.1-5 Whatever your facility protocol, the nPulse platform has the lowest measured displacement and blood reflux of market leading valves.3 It features neutral fluid displacement at ...
Manufactured by:Haemonetics Corporation based inBoston, MASSACHUSETTS (USA)
The TEG 6s system, in combination with clinical information, provides rapid, comprehensive and accurate identification of an individual’s hemostasis condition. Featuring an innovative, all-in-one cartridge, the TEG 6s delivers the same quality test results without the complicated test preparation process. TEG 6s allows clinicians to drive personalized, clinically and economically sound ...
Manufactured by:MorphoSys AG based inPlanegg, GERMANY
Tafasitamab (MOR208) is a humanized FC-modified CD19 targeting immunotherapy in clinical development for the treatment of B cell malignancies. CD19 is broadly expressed on the surface of B cells. It is therefore considered as a potential target for the treatment of B cell malignancies, such as non-Hodgkin’s lymphoma (NHL), including diffuse large B cell lymphoma (DLBCL), indolent lymphomas ...
Manufactured by:Alkermes based inDublin 4, IRELAND
ARISTADA® (aripiprazole lauroxil) extended-release injectable suspension is a long-acting atypical antipsychotic that is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia in adults. ARISTADA is available in four dose strengths with once-monthly dosing (441 mg, 662 mg, 882 mg), a six-week dosing option (882 mg) and a two-month dosing option (1064 ...